IN A NUTSHELL:
Scientist, entrepreneur, and investor Steve Gullans has a unique vantage point into the future of drug discovery and dosing.
Steve is an experienced investor, entrepreneur, writer, and scientist. At Excel Venture, he focuses on life science technology companies with a particular interest in disruptive platforms that can impact multiple industries. Steve was a faculty member at Harvard Medical School and Brigham and Women's Hospital for nearly 20 years. He has published more than 130 scientific papers touching many areas of biology and medicine, lectured internationally, and co-authored numerous patents. He and Juan Enriquez recently co-authored Homo Evolutis: A Short Tour of Our New Species, which describes the future of human evolution, as well as a recent commentary in Nature entitled Genetically Enhanced Olympics are Coming.